RESUMEN
PURPOSE: During the past 10 years, the acoustic analysis of breath sounds has been used as a diagnostic tool in patients suffering from obstructive respiratory diseases. Acoustic analysis might be able to monitor the response to bronchodilator therapy in a clinical setting. So far, few studies have been carried out in asthmatic patients. To assess the responses of a sampling of asthma patients to an inhaled bronchodilator (terbutaline) by means of spectral analysis of the tracheal sound performed during forced expiratory maneuvers. MATERIAL AND METHODS: Seventeen nonsmoking asthma patients (9 were male, 8 were female) who had been suffering from the disease for > or = 15 years were included in the study, as were 15 normal subjects (7 were male, 8 were female). The average age (+/- SD) was 56.5 +/- 15.2 years (FVC, 2.7 +/- 0.9 L [63.4%]; FEV1, 1.5 +/- 0.6 L [53.0%]). The tracheal sounds were collected during three forced expiratory maneuvers with a sampling frequency of 5,000 Hz and were analyzed by applying a 16-parameter autoregressive model. RESULTS: The centroid frequency decreased after the bronchodilator was given at different flow segments between 1.2 and 0.4 L/s, with significant changes between 0.6 and 0.4 L/s. CONCLUSIONS: Patients with asthma showed changes in the spectral acoustic analysis frequencies after the administration of a bronchodilator drug (terbutaline) during forced expiratory maneuvers.